Annual Long Term Debt
$116.67 M
+$67.38 M+136.70%
December 31, 2023
Summary
- As of February 24, 2025, MDGL annual long term debt is $116.67 million, with the most recent change of +$67.38 million (+136.70%) on December 31, 2023.
- During the last 3 years, MDGL annual long term debt has risen by +$116.20 million (+24828.63%).
- MDGL annual long term debt is now at all-time high.
Performance
MDGL Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$118.26 M
+$756.00 K+0.64%
September 30, 2024
Summary
- As of February 24, 2025, MDGL quarterly long term debt is $118.26 million, with the most recent change of +$756.00 thousand (+0.64%) on September 30, 2024.
- Over the past year, MDGL quarterly long term debt has increased by +$756.00 thousand (+0.64%).
- MDGL quarterly long term debt is now at all-time high.
Performance
MDGL Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
MDGL Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +136.7% | +0.6% |
| 3 y3 years | +10000.0% | +0.6% |
| 5 y5 years | +100.0% | +0.6% |
MDGL Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Madrigal Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $118.26 M(+0.6%) |
| Jun 2024 | - | $117.51 M(+0.3%) |
| Mar 2024 | - | $117.18 M(+0.4%) |
| Dec 2023 | $116.67 M(+136.7%) | $116.67 M(+0.5%) |
| Sep 2023 | - | $116.05 M(+16.9%) |
| Jun 2023 | - | $99.25 M(+18.2%) |
| Mar 2023 | - | $83.97 M(+70.4%) |
| Dec 2022 | $49.29 M(>+9900.0%) | $49.29 M(+0.5%) |
| Sep 2022 | - | $49.05 M(+0.4%) |
| Jun 2022 | - | $48.85 M(>+9900.0%) |
| Mar 2022 | - | $283.00 K(-26.9%) |
| Dec 2021 | $387.00 K(-17.3%) | $387.00 K(-21.2%) |
| Sep 2021 | - | $491.00 K(-17.3%) |
| Jun 2021 | - | $594.00 K(+53.5%) |
| Mar 2021 | - | $387.00 K(-17.3%) |
| Dec 2020 | $468.00 K(+29.6%) | $468.00 K(-14.6%) |
| Sep 2020 | - | $548.00 K(+178.2%) |
| Jun 2020 | - | $197.00 K(-29.4%) |
| Mar 2020 | - | $279.00 K(-22.7%) |
| Dec 2019 | $361.00 K(>+9900.0%) | $361.00 K(-18.1%) |
| Sep 2019 | - | $441.00 K(-15.2%) |
| Jun 2019 | - | $520.00 K(-13.0%) |
| Mar 2019 | - | $598.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2015 | - | $11.00 K(-65.6%) |
| Jun 2015 | - | $32.00 K(-98.6%) |
| Mar 2015 | - | $2.33 M(-49.8%) |
| Dec 2014 | $4.65 M(-66.6%) | $4.65 M(-33.3%) |
| Sep 2014 | - | $6.97 M(-24.9%) |
| Jun 2014 | - | $9.28 M(-19.9%) |
| Mar 2014 | - | $11.60 M(-16.6%) |
| Dec 2013 | $13.90 M | $13.90 M(-13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $16.12 M(-12.5%) |
| Jun 2013 | - | $18.42 M(-10.4%) |
| Mar 2013 | - | $20.55 M(+360.1%) |
| Dec 2012 | $4.46 M(-64.0%) | $4.46 M(-30.9%) |
| Sep 2012 | - | $6.46 M(-23.5%) |
| Jun 2012 | - | $8.45 M(-19.0%) |
| Mar 2012 | - | $10.43 M(-15.9%) |
| Dec 2011 | $12.40 M(+6.1%) | $12.40 M(+1.9%) |
| Sep 2011 | - | $12.17 M(-12.0%) |
| Jun 2011 | - | $13.84 M(+20.4%) |
| Mar 2011 | - | $11.49 M(-1.7%) |
| Dec 2010 | $11.69 M(+1363.5%) | $11.69 M(-12.5%) |
| Sep 2010 | - | $13.37 M(+4091.2%) |
| Jun 2010 | - | $319.00 K(-39.6%) |
| Mar 2010 | - | $528.00 K(-33.9%) |
| Dec 2009 | $799.00 K(-60.3%) | $799.00 K(-26.8%) |
| Sep 2009 | - | $1.09 M(-21.8%) |
| Jun 2009 | - | $1.40 M(-86.4%) |
| Mar 2009 | - | $10.26 M(+409.8%) |
| Dec 2008 | $2.01 M(-28.5%) | $2.01 M(-12.6%) |
| Sep 2008 | - | $2.30 M(-19.1%) |
| Jun 2008 | - | $2.84 M(+10.9%) |
| Mar 2008 | - | $2.56 M(-9.0%) |
| Dec 2007 | $2.81 M(-11.2%) | $2.81 M(-9.7%) |
| Sep 2007 | - | $3.12 M(-4.6%) |
| Jun 2007 | - | $3.27 M(-3.0%) |
| Mar 2007 | - | $3.37 M(+6.2%) |
| Dec 2006 | $3.17 M(-25.6%) | $3.17 M(-7.4%) |
| Sep 2006 | - | $3.42 M(-19.6%) |
| Dec 2005 | $4.26 M(+258.5%) | $4.26 M(+170.9%) |
| Mar 2005 | - | $1.57 M |
| Dec 2004 | $1.19 M(>+9900.0%) | - |
| Dec 2001 | $0.00 | - |
FAQ
- What is Madrigal Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual long term debt year-on-year change?
- What is Madrigal Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly long term debt year-on-year change?
What is Madrigal Pharmaceuticals annual long term debt?
The current annual long term debt of MDGL is $116.67 M
What is the all time high annual long term debt for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual long term debt is $116.67 M
What is Madrigal Pharmaceuticals annual long term debt year-on-year change?
Over the past year, MDGL annual long term debt has changed by +$67.38 M (+136.70%)
What is Madrigal Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of MDGL is $118.26 M
What is the all time high quarterly long term debt for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly long term debt is $118.26 M
What is Madrigal Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, MDGL quarterly long term debt has changed by +$756.00 K (+0.64%)